Evelo Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Evelo Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2022.
  • Evelo Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $2.48M, a 28.5% decline year-over-year.
  • Evelo Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $11.2M, a 30.6% decline year-over-year.
  • Evelo Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.2M, a 4.34% decline from 2021.
  • Evelo Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15.8M, a 87.1% increase from 2020.
  • Evelo Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $8.47M, a 3.71% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $15.2M -$688K -4.34% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $15.8M +$7.38M +87.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $8.47M +$303K +3.71% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $8.17M +$2.11M +34.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $6.06M +$4.52M +293% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 $1.54M +$1.12M +268% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 $419K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.